Anzeige
Mehr »
Login
Dienstag, 21.05.2024 Börsentäglich über 12.000 News von 688 internationalen Medien
Die Wachstumsgeschichte: Analysten sehen kurzfristige +37 %-Chance bei diesem europäischen Marktführer
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

Übersicht Suchergebnisse zum Thema ANIXA BIOSCIENCES INC.

ZeitNachrichten
Sprache: Alle DE EN
LeserMedien
13:30Anixa Biosciences, Inc.: Anixa Biosciences Commences Treatment of Fifth Patient in Ovarian Cancer CAR-T Clinical Trial78Novel and proprietary CAR-T approach holds potential to be first effective CAR-T therapy for solid tumors SAN JOSE, Calif., May 21, 2024 /PRNewswire/ -- Anixa Biosciences, Inc. ("Anixa" or the...
► Artikel lesen
08.05.Anixa Biosciences Inc - 8-K, Current Report1
08.05.Anixa Biosciences, Inc.: Anixa Biosciences Expands Partnership with Cleveland Clinic to Develop Additional Cancer Vaccines69- Company currently collaborates with Cleveland Clinic on breast cancer and ovarian cancer vaccines - SAN JOSE, Calif., May 8, 2024 /PRNewswire/ -- Anixa Biosciences, Inc. ("Anixa" or the "Company")...
► Artikel lesen
22.03.Anixa Biosciences Inc - 8-K, Current Report4
12.03.Anixa Biosciences Inc - 10-Q, Quarterly Report1
12.02.Anixa Biosciences, Inc.: Anixa Biosciences Initiates Dosing in Second Cohort of Ovarian Cancer CAR-T Clinical Trial619Dose escalation for fourth patient follows successful completion of first cohort SAN JOSE, Calif., Feb. 12, 2024 /PRNewswire/ -- Anixa Biosciences, Inc. ("Anixa" or the "Company") (NASDAQ: ANIX)...
► Artikel lesen
23.01.Anixa Biosciences, Inc.: Anixa Biosciences Announces Japanese Patent on Ovarian Cancer Vaccine Technology386Broad coverage extended to Japan and related regions SAN JOSE, Calif., Jan. 23, 2024 /PRNewswire/ -- Anixa Biosciences, Inc. ("Anixa" or the "Company") (NASDAQ: ANIX), a clinical-stage biotechnology...
► Artikel lesen
16.01.Anixa Biosciences Inc - S-8, Securities to be offered to employees in employee benefit plans2
16.01.Anixa Biosciences Inc - 10-K, Annual Report2
07.12.23Anixa Biosciences Inc - 8-K, Current Report2